A checklist for clinical trials in rare disease

This tool is associated with the following interest areas: Industry, Sites

This paper, titled 'A checklist for clinical trials in rare disease: obstacles and anticipatory actions - lessons learned from the FOR-DMD trial', outlines the challenges and lessons learned from the FOR-DMD trial about running trials in the rare disease space. 

A checklist for clinical trials in rare disease: obstacles and anticipatory actions - lessons learned from the FOR-DMD trial. - Rebecca A. Crow et. al. 

Read the paper here

We have placed cookies on your computer to help make this website better. For more information please click here

By continuing to use this site or closing this panel, we'll assume you're OK to continue. You can view our full privacy policy here